Keros Therapeutics, Inc. (KROS)
9.36
-0.09
(-0.95%)
USD |
NASDAQ |
Nov 06, 16:00
9.315
-0.04
(-0.48%)
After-Hours: 20:00
Keros Therapeutics EPS Diluted (Quarterly) : -1.45 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.45 |
| March 31, 2026 | -1.208 |
| December 31, 2025 | -0.8626 |
| September 30, 2025 | -0.1792 |
| June 30, 2025 | -0.7558 |
| March 31, 2025 | 3.619 |
| December 31, 2024 | -1.141 |
| September 30, 2024 | -1.409 |
| June 30, 2024 | -1.254 |
| March 31, 2024 | -1.208 |
| December 31, 2023 | -1.336 |
| September 30, 2023 | -1.329 |
| June 30, 2023 | -1.267 |
| March 31, 2023 | -1.262 |
| December 31, 2022 | -1.088 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.9201 |
| June 30, 2022 | -1.134 |
| March 31, 2022 | -1.008 |
| December 31, 2021 | -0.2961 |
| September 30, 2021 | -0.8688 |
| June 30, 2021 | -0.6703 |
| March 31, 2021 | -0.6838 |
| December 31, 2020 | -0.4937 |
| September 30, 2020 | -0.5963 |
| June 30, 2020 | -0.622 |
| March 31, 2020 | -0.6302 |
| December 31, 2019 | -0.1589 |
| September 30, 2019 | -0.1985 |
| June 30, 2019 | -1.444 |
| March 31, 2019 | -0.1803 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -28.71M |
| Total Expenses (Quarterly) | 28.71M |
| Enterprise Value | -56.30M |
| Earnings Yield | -39.53% |
| Normalized Earnings Yield | -39.50 |